Carinne Knoche-Brouillon
Director/Board Member bei MUNICH RE
Profil
Carinne Knoche-Brouillon is currently the Co-Managing Director at Boehringer Ingelheim Corporate Center GmbH.
He is also an Independent Member-Supervisory Board at Münchener Rückversicherungs-Gesellschaft AG and a Member-Management Board at C.H.
Boehringer Sohn AG & Co. KG.
In the past, Mr. Knoche-Brouillon worked as a Manager-Marketing at bioMérieux SA from 1991 to 1995.
He was also a Manager-Business Development at Valorum from 1996 to 1997.
Additionally, he served as the Global Head-Therapeutic Areas at Boehringer Ingelheim International GmbH from 2018 to 2019 and as the Head-Global Commercial Strategy at Janssen Global Services LLC from 2014 to 2018.
Prior to that, he was the President of Janssen Therapeutics, Inc. from 2012 to 2014.
Mr. Knoche-Brouillon obtained his graduate degree from Institut de Pharmacie Industrielle de Lyon in 1990.
Aktive Positionen von Carinne Knoche-Brouillon
| Unternehmen | Position | Beginn |
|---|---|---|
| MUNICH RE | Director/Board Member | 28.04.2021 |
C.H. Boehringer Sohn AG & Co. KG
 C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 01.01.2020 |
Boehringer Ingelheim Corporate Center GmbH
 Boehringer Ingelheim Corporate Center GmbH Real Estate DevelopmentFinance Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The private company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Carinne Knoche-Brouillon
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Corporate Officer/Principal | 01.01.2019 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01.01.2018 |
| Janssen Therapeutics, Inc. | President | 01.01.2014 |
| Valorum | Corporate Officer/Principal | 01.01.1997 |
| BIOMÉRIEUX | Sales & Marketing | 01.01.1995 |
Ausbildung von Carinne Knoche-Brouillon
| Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MUNICH RE | Finance |
| BIOMÉRIEUX | Health Technology |
| Private Unternehmen | 6 |
|---|---|
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
| Valorum | Health Technology |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Health Technology |
| Janssen Therapeutics, Inc. | |
Boehringer Ingelheim Corporate Center GmbH
Boehringer Ingelheim Corporate Center GmbH Real Estate DevelopmentFinance Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The private company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
